Clinical trial
Safety and Efficacy Study of Topiramate to Aid in Smoking Cessation
NCT00280839 · Lindner Center of HOPE, Other · Completed
Key facts
| NCT number | NCT00280839 |
|---|---|
| Title | Safety and Efficacy Study of Topiramate to Aid in Smoking Cessation |
| Official title | A Double-Blind, Placebo-Controlled, 11-Week Trial of Topiramate as an Aid to Smoking Cessation |
| Lead sponsor | Lindner Center of HOPE, Other |
| Collaborators | Ortho-McNeil Neurologics, Inc. Industry University of Cincinnati |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Smoking Cessation |
| Intervention type | Drug |
| Interventions | Topiramate, Placebo |
| Enrollment | 87 |
| First posted | Sep 22, 2005 |
| Last update posted | Apr 13, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: